Newborn affected by maternal use of cocaine

This code signifies a newborn who exhibits signs or symptoms of exposure to cocaine due to maternal use during pregnancy. This exposure can lead to various neurological, developmental, and physiological complications in the neonate. The effects are a direct consequence of the drug crossing the placental barrier.

Apply this code when documentation clearly indicates maternal cocaine use during pregnancy and the newborn is being treated for conditions or exhibiting symptoms directly attributable to this exposure. Supporting documentation includes maternal history of substance abuse, positive toxicology screens (maternal or neonatal), and clinical findings consistent with prenatal cocaine exposure.

• Always sequence this code as a secondary diagnosis, following the code for the specific condition or symptom the newborn is experiencing (e.g., neonatal abstinence syndrome, prematurity).
• Do not use this code if the maternal cocaine use is merely noted but there are no documented effects on the newborn.
• Distinguish from other maternal substance abuse codes; ensure the documentation specifically mentions cocaine.